BlackBarn Capital Partners »

Amneal Pharmaceuticals shares owned by BlackBarn Capital Partners

Quarter-by-quarter ownership of Amneal Pharmaceuticals (AMRX) shares owned by BlackBarn Capital Partners from 13F filings

Historical chart of BlackBarn Capital Partners investment in Amneal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amneal Pharmaceuticals held by BlackBarn Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amneal Pharmaceuticals by BlackBarn Capital Partners

Quarter filed Position value Share count Share price at filing
2024-06-30 $13M 2.0M 6.35
2024-03-31 $8.6M 1.4M 6.06

More positions owned by BlackBarn Capital Partners

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
NVIDIA Corporation Put Option (NVDA)
Coinbase Global Com Cl A Put Option (COIN)
Roivant Sciences SHS (ROIV)
UnitedHealth (UNH)
Molina Healthcare (MOH)
Amneal Pharmaceuticals Com Stk Cl A (AMRX)
Blue Ridge Bank (BRBS)
Diversified Healthcare Tr Com Sh Ben Int (DHC)
At&t (T)
Oddity Tech Shs Cl A Put Option (ODD)
Chord Energy Corporation Com New (CHRD)
Rh (RH)
Anthem (ELV)
Civitas Resources Com New (CIVI)

View all positions for BlackBarn Capital Partners

Top funds holding Amneal Pharmaceuticals

Vanguard Group
Tpg Gp A
BlackRock
Rubric Capital Management
Citadel Advisors
Fosun International
Dimensional Fund Advisors
Neuberger Berman Group
Geode Capital Management
State Street Corporation
Nantahala Capital Management
Nuveen Asset Management
BlackBarn Capital Partners
Hennessy Advisors
Goldman Sachs Group

View all funds holding Amneal Pharmaceuticals